305 related articles for article (PubMed ID: 8628299)
1. Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing.
Gontarek RR; Derse D
Mol Cell Biol; 1996 May; 16(5):2325-31. PubMed ID: 8628299
[TBL] [Abstract][Full Text] [Related]
2. Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA.
Chung H ; Derse D
J Biol Chem; 2001 Jun; 276(22):18960-7. PubMed ID: 11278454
[TBL] [Abstract][Full Text] [Related]
3. Binding of equine infectious anemia virus rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs.
Belshan M; Park GS; Bilodeau P; Stoltzfus CM; Carpenter S
Mol Cell Biol; 2000 May; 20(10):3550-7. PubMed ID: 10779344
[TBL] [Abstract][Full Text] [Related]
4. cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing.
Liao HJ; Baker CC; Princler GL; Derse D
Virology; 2004 May; 323(1):131-40. PubMed ID: 15165825
[TBL] [Abstract][Full Text] [Related]
5. Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing.
Martarano L; Stephens R; Rice N; Derse D
J Virol; 1994 May; 68(5):3102-11. PubMed ID: 8151775
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional characterization of rev-like transcripts of equine infectious anemia virus.
Rosin-Arbesfeld R; Rivlin M; Noiman S; Mashiah P; Yaniv A; Miki T; Tronick SR; Gazit A
J Virol; 1993 Sep; 67(9):5640-6. PubMed ID: 8394464
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Novel Post-transcriptional Transactivator from the Equine Infectious Anemia Virus.
Li J; Zhang X; Bai B; Zhang M; Ma W; Lin Y; Wang X; Wang XF
J Virol; 2022 Dec; 96(24):e0121022. PubMed ID: 36448796
[TBL] [Abstract][Full Text] [Related]
8. Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative Rev proteins.
Stephens RM; Derse D; Rice NR
J Virol; 1990 Aug; 64(8):3716-25. PubMed ID: 2164593
[TBL] [Abstract][Full Text] [Related]
9. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
Amendt BA; Si ZH; Stoltzfus CM
Mol Cell Biol; 1995 Aug; 15(8):4606-15. PubMed ID: 7623852
[TBL] [Abstract][Full Text] [Related]
10. Muscle-specific exonic splicing silencer for exon exclusion in human ATP synthase gamma-subunit pre-mRNA.
Hayakawa M; Sakashita E; Ueno E; Tominaga S; Hamamoto T; Kagawa Y; Endo H
J Biol Chem; 2002 Mar; 277(9):6974-84. PubMed ID: 11744705
[TBL] [Abstract][Full Text] [Related]
11. The strength of the HIV-1 3' splice sites affects Rev function.
Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
[TBL] [Abstract][Full Text] [Related]
12. Specific binding of an exonic splicing enhancer by the pre-mRNA splicing factor SRp55.
Nagel RJ; Lancaster AM; Zahler AM
RNA; 1998 Jan; 4(1):11-23. PubMed ID: 9436904
[TBL] [Abstract][Full Text] [Related]
13. A complex of nuclear proteins mediates SR protein binding to a purine-rich splicing enhancer.
Yeakley JM; Morfin JP; Rosenfeld MG; Fu XD
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7582-7. PubMed ID: 8755518
[TBL] [Abstract][Full Text] [Related]
14. A Novel, Fully Spliced, Accessory Gene in Equine Lentivirus with Distinct Rev-Responsive Element.
Zhang X; Li J; Zhang M; Bai B; Ma W; Lin Y; Guo X; Wang XF; Wang X
J Virol; 2022 Sep; 96(18):e0098622. PubMed ID: 36069548
[TBL] [Abstract][Full Text] [Related]
15. hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure.
Damgaard CK; Tange TO; Kjems J
RNA; 2002 Nov; 8(11):1401-15. PubMed ID: 12458794
[TBL] [Abstract][Full Text] [Related]
16. Translation of equine infectious anemia virus bicistronic tat-rev mRNA requires leaky ribosome scanning of the tat CTG initiation codon.
Carroll R; Derse D
J Virol; 1993 Mar; 67(3):1433-40. PubMed ID: 8382305
[TBL] [Abstract][Full Text] [Related]
17. Characterization of functional domains of equine infectious anemia virus Rev suggests a bipartite RNA-binding domain.
Lee JH; Murphy SC; Belshan M; Sparks WO; Wannemuehler Y; Liu S; Hope TJ; Dobbs D; Carpenter S
J Virol; 2006 Apr; 80(8):3844-52. PubMed ID: 16571801
[TBL] [Abstract][Full Text] [Related]
18. Molecular and biological characterization of equine infectious anemia virus Rev.
Carpenter S; Dobbs D
Curr HIV Res; 2010 Jan; 8(1):87-93. PubMed ID: 20210784
[TBL] [Abstract][Full Text] [Related]
19. Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains.
Bilodeau PS; Domsic JK; Stoltzfus CM
J Virol; 1999 Dec; 73(12):9764-72. PubMed ID: 10559286
[TBL] [Abstract][Full Text] [Related]
20. Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1.
Staffa A; Cochrane A
Mol Cell Biol; 1995 Aug; 15(8):4597-605. PubMed ID: 7623851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
